Abbisko Therapeutics Deepens R&D Collaboration with Lilly
SHANGHAI, June 24, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic research collaboration and license agreement with Eli Lilly and Company ("Lilly"), a leading global pharmaceutical company. Under the agreement, the two companies will collaborate on the...
Mabwell Receives IND Clearance from NMPA for LILRB4/CD3-targeting TCE Bispecific Antibody 6MW5311
SHANGHAI, June 24, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) of China has cleared the clinical trial application for its innovative LILRB4/CD3 targeting T Cell Engager (TCE) bispecific antibody (R&D code: 6MW5311), for the treatment of hematologic malignancies, including acute myeloid...
Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership
ABU DHABI, UAE, June 24, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership...
TraceLink Named Fortress Cybersecurity Awards Finalist for Enabling the Transformation to a Secure, Auditable Agentic Supply Chain Operating Model
OPUS Platform and OPUS Agents recognized for enabling no-code AI agents to operate as permissioned, traceable participants in regulated pharmaceutical supply chain operations Summary TraceLink has been named a finalist in the 2026 Fortress Cybersecurity Awards for OPUS and OPUS Agents. The recognition highlights TraceLink's ability to support agentic supply chain...
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
BEIJING, June 23, 2026 /PRNewswire/ -- On June 23, 2026 (Beijing time), Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco has granted Nuvectis the exclusive rights to develop, manufacture, and commercialize its independently developed innovative drug HSK42360 worldwide, excluding...
Chenwei Medical Showcases Advanced ICU Ventilators, Anesthesia Workstations and Emergency Transport Ventilator Solutions at WHX Miami 2026
MIAMI, June 23, 2026 /PRNewswire/ -- Following its participation in the AMCI International Critical Care Congress in Colombia, Chenwei Medical presented its latest innovations in ICU ventilation, anesthesia systems and emergency respiratory care at WHX Miami 2026. Chenwei Medical at WHX Miami 2026 (Booth C53), showcasing advanced Anesthesia Systems, Ventilators, Patient Monitors, and Smart Healthcare Solutions. ...
EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services
PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. The upgraded space has more than doubled the company's laboratory footprint, expanding the CRO's capacity to support advanced immunological testing. This investment reflects growing demand...
TriNetX LIVE™ Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
The milestone reflects accelerating international growth and gives pharmaceutical companies, academic researchers, healthcare providers, and health-tech innovators access to trusted, current, clinically rich, and globally representative real-world data. CAMBRIDGE, Mass., June 23, 2026 /PRNewswire/ -- TriNetX, the world's leading federated health data network, today announced that its TriNetX LIVE™ network has...
Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital
Frost & Sullivan identifies significant opportunities across ambulatory surgery, digital health, and connected care markets LONDON, June 23, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis highlights ambulatory surgical centres (ASCs) as one of the most significant growth opportunities reshaping healthcare delivery worldwide. Driven by rising demand for efficient, cost-effective, and patient-centric care, the global ASC market is...
BedStory® Launches BEDSTORY SPINEALIGN® and Cooling Collection Sleep Systems as Demand Grows for Precision-Tuned Support and Cooler Sleep
FOLSOM, Calif., June 23, 2026 /PRNewswire/ -- In response to growing consumer demand for sleep solutions that support both healthy sleep posture and thermal comfort, BedStory®, a family-focused healthy sleep brand trusted by millions of sleepers worldwide, today announced the North American launch of its new BEDSTORY SPINEALIGN® and Cooling Collection mattress series. The launch comes as the...
